An Advanced Formulation of a Magnesium Dietary Supplement Adapted for a Long-Term Use Supplementation Improves Magnesium Bioavailability: In Vitro and Clinical Comparative Studies
While general recommendations are for 300-mg magnesium intake a day, an advanced low-dose formulation of magnesium chloride, ChronoMag®, was designed to provide 100 mg of magnesium element, thus decreasing the risk of gastrointestinal side effects and allowing long-term supplementation in health conditions related to low magnesium levels. The present study aimed to compare magnesium release profile and bioavailability between this patented low-dose continuous-release magnesium chloride tablet (100 mg magnesium element) and a reference tablet at the usually prescribed dose (300 mg magnesium element). Magnesium release profile was determined by dissolving the tablets in solutions simulating the gastrointestinal tract environment. A randomized double-blind crossover controlled trial of ChronoMag® versus reference tablet (3 × 100 mg magnesium element tablets) in 12 normo-magnesemic healthy volunteers was conducted to evaluate the bioavailability of the patented magnesium chloride tablets (two 50 mg magnesium tablets, once-a-day intake). While the reference tablet released 100% of its magnesium within 1 h of dissolution, release from the magnesium chloride formulation was continuous for 6 h. Cumulative urinary magnesium levels compared to those with the reference tablet were 76% (0–5 h), 89% (0–10 h), and 87% (0–24 h). Elimination after 24 h was fairly similar with both supplements. Our results suggest that the new magnesium chloride formulation, providing continuous low-dose magnesium release throughout the gastrointestinal tract, improves absorption and bioavailability. This formulation conforms to the physiological mechanism of magnesium absorption throughout the digestive tract, allowing high absorption, and may improve gastrointestinal tolerance in long-term use.
KeywordsMagnesium element Magnesium chloride Low dose Continuous release Improved absorption Long-term supplementation
We would like to thank Pr. A. Berthelot, Dr. B. Shroot, Y. Marchenay, and Dr. Y. Juillet for their intellectual contribution to the study.
This study was sponsored by FJ LIFE SCIENCES.
Compliance with Ethical Standards
The randomized, double-blind, crossover, controlled trial in healthy volunteers (registration number with the French health products safety agency, ANSM: 2013-001631-43; ClinicalTrials.gov trial number: NCT01935570) was conducted in the Clinical Pharmacology Center of the University Hospital of Clermont-Ferrand (France), in compliance with the principles of the Declaration of Helsinki and following Good Clinical Practices. Review board approval (CPP Sud-Est VI, Clermont-Ferrand, France) was obtained before the start of the study. Subjects were enrolled after giving written informed consent and fulfilling inclusion and exclusion criteria. Dr. Joanny declares she is the Founder and CEO of FJ LIFE SCIENCES.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 12.Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F (2016) A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 111:272–282. https://doi.org/10.1016/j.phrs.2016.06.019 CrossRefPubMedGoogle Scholar
- 14.Joris PJ, Plat J, Bakker SJ, Mensink RP (2016) Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial. Am J Clin Nutr 103:1260–1266. https://doi.org/10.3945/ajcn.116.131466 CrossRefPubMedGoogle Scholar
- 16.Posadas-Sánchez R, Posadas-Romero C, Cardoso-Saldaña G, Vargas-Alarcón G, Villarreal-Molina MT, Pérez-Hernández N, Rodríguez-Pérez JM, Medina-Urrutia A, Jorge-Galarza E, Juárez-Rojas JG, Torres-Tamayo M (2016) Serum magnesium is inversely associated with coronary artery calcification in the genetics of atherosclerotic disease (GEA) study. Nutr J 15:22. https://doi.org/10.1186/s12937-016-0143-3 CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Abbasi B, Kimiagar M, Sadeghniiat K et al (2012) The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci Off J Isfahan Univ Med Sci 17:1161Google Scholar
- 23.Proctor ML, Murphy PA (2001) Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev CD002124. doi: https://doi.org/10.1002/14651858.CD002124
- 26.Stanisławska M, Szkup-Jabłońska M, Jurczak A, Wieder-Huszla S, Samochowiec A, Jasiewicz A, Noceń I, Augustyniuk K, Brodowska A, Karakiewicz B, Chlubek D, Grochans E (2014) The severity of depressive symptoms vs. serum Mg and Zn levels in postmenopausal women. Biol Trace Elem Res 157:30–35. https://doi.org/10.1007/s12011-013-9866-6 CrossRefPubMedGoogle Scholar
- 29.Institute of Medicine (1997) Food and nutrition board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press, Washington, DCGoogle Scholar
- 32.Coudray C, Rambeau M, Feillet-Coudray C et al (2005) Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res Off Organ Int Soc Dev Res Magnes 18:215–223Google Scholar
- 33.Firoz M, Graber M (2001) Bioavailability of US commercial magnesium preparations. Magnes Res Off Organ Int Soc Dev Res Magnes 14:257–262Google Scholar
- 36.Joanny F (2011) Use of a matrix for orally administering sustained release magnesium, and composition containing said matrixGoogle Scholar
- 37.Dissolution test for solid dosage forms. In: Eur. Pharmacopoeia, 8.0. pp 288–295Google Scholar
- 42.Sabatier M, Grandvuillemin A, Kastenmayer P, Aeschliman JM, Bouisset F, Arnaud MJ, Dumoulin G, Berthelot A (2011) Influence of the consumption pattern of magnesium from magnesium-rich mineral water on magnesium bioavailability. Br J Nutr 106:331–334. https://doi.org/10.1017/S0007114511001139 CrossRefPubMedGoogle Scholar